Molecular Biology

, Volume 40, Issue 2, pp 228–234

Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women

  • E. G. Shatalova
  • V. I. Loginov
  • E. A. Braga
  • T. P. Kazubskaja
  • M. A. Sudomoina
  • R. L. Blanchard
  • O. O. Favorova
Genomics. Transcriptomics. Proteomics

Abstract

Estrogens are critical for breast cancer initiation and development. Sulfotransferase 1A1 (SULT1A1) and UDP-glucuronosyltransferase 1A1 (UGT1A1) conjugate and inactivate both estrogens and their metabolites, thus preventing estrogen-mediated mitosis and mutagenesis. SULT1A1 and UGT1A1 are both polymorphic, and different alleles encode functionally different allozymes. We hypothesize that low-activity alleles SULT1A1*2 and UGT1A1*28 are associated with higher risk for breast cancer and more severe breast tumor phenotypes. We performed a case-control study, which included 119 women of Russian ancestry with breast cancer and 121 age-matched Russian female controls. We used PCR followed by pyrosequencing to determine the SULT1A1 and UGT1A1 genotypes. Allele UGT1A1*28 was present at a higher frequency than the wild-type UGT1A1*1 allele in breast cancer patients as compared to controls (P = 0.002, OR = 1.79, CI 1.23–2.63). Consistently, the frequency of genotypes that contain allele UGT1A1*28 in the homozygous or the heterozygous state was greater in breast cancer patients as compared with the frequency of the wild-type UGT1A1*1/*1 genotype (P = 0.003, OR = 4.00, CI 1.49–11.11 and P = 0.014, OR = 2.04, CI 1.14–3.57, respectively). Individuals carrying allele UGT1A1*28 in the homo-or heterozygous state had larger breast tumors (>2 cm) as compared to the group with high-activity genotypes (P = 0.011, IR = 3.44, CI 1.42–8.36). No association was observed between any of the SULT1A1 genotypes and breast cancer risk or phenotypes. Our data suggest that UGT1A1, but not SULT1A1, genotypes are important for breast cancer risk and phenotype in Russian women.

Key words

human breast cancer genotyping estrogen sulfotransferase 1A1 UDP-glucoronosyltransferase 1A1 SULT1A1 UGT1A1 allelic polymorphism functional genomics 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zdorov’e rabotayushchego naseleniya. Opyt territorial’nykh organov ispolnitel’noi vlasti v oblasti realizatsii programm po profilaktike i lecheniyu onkologicheskikh zabolevanii u zhenshchin: press-reliz (Working Population Health: Experience of Regional Administrations in Implementing Programs of Prevention and Treatment of Oncological Diseases in Women. A Press Release). 2004. In the Press.ru (http://medicine.intherpress.ru/v/12340.html).
  2. 2.
    Federal’nyi mammologicheskii tsentr: Statistika (Federal Mammary Gland Disease Center: Statistics). 2005. (http://www.mammo.ru/view_topic.asp?ID=1&ID-Topic-5).
  3. 3.
    Pasqualini J.R. 2004. The selective estrogen enzyme modulators in breast cancer: A review. Biochim. Biophys. Acta. 1654, 123–143.PubMedGoogle Scholar
  4. 4.
    Ivanov V.G. 2002. Factors of epidemiological risk and early diagnosis of breast cancer. Prakt. Onkol. 3, 1–6.Google Scholar
  5. 5.
    Safe S.H. 1998. Interactions between hormones and chemicals in breast cancer. Annu. Rev. Pharmacol. Toxicol. 38, 121–158.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhu B.T., Conney A.H. 1998. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis. 19, 1–27.PubMedGoogle Scholar
  7. 7.
    Yager J.D., Liehr J.G. 1996. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203–232.CrossRefPubMedGoogle Scholar
  8. 8.
    Stack D.E., Byun J., Gross M.L., Rogan E.G., Cavalieri E.L. 1996. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851–859.CrossRefPubMedGoogle Scholar
  9. 9.
    Cavalieri E.L., Stack D.E., Devanesan P.D., et al. 1997. Molecular origin of cancer: Catechol estrogen-3.4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA. 94, 10 937–10 942.CrossRefGoogle Scholar
  10. 10.
    Weinshilboum R.M., Otterness D.M., Aksoy I.A., Wood T.C., Her C., Raftogianis R.B. 1997. Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11, 3–14.PubMedGoogle Scholar
  11. 11.
    Lepine J., Bernard O., Plante M., Tetu B., Pelletier G., Labrie F., Belanger A., Guillemette C. 2004. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J. Clin. Endocrinol. Metab. 89, 5222–5232.CrossRefPubMedGoogle Scholar
  12. 12.
    Ebner T., Burchell B. 1993. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab. Dispos. 21, 50–55.PubMedGoogle Scholar
  13. 13.
    Falany C.N. 1997. Enzymology of human cytosolic sulfotransferases. FASEB J. 11, 206–216.PubMedGoogle Scholar
  14. 14.
    Adjei A.A., Weinshilboum R.M. 2002. Catecholestrogen sulfation: Possible role in carcinogenesis. Biochem. Biophys. Res. Commun. 292, 402–408.CrossRefPubMedGoogle Scholar
  15. 15.
    Falany C.N., Wheeler J., Oh T.S., Falany J.L. 1994. Steroid sulfation by expressed human cytosolic sulfotransferases. J. Steroid Biochem. Mol. Biol. 48, 369–375.CrossRefPubMedGoogle Scholar
  16. 16.
    Falany J.L., Lawing L., Falany C.N. 1993. Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells. J. Steroid Biochem. Mol. Biol. 46, 481–487.CrossRefPubMedGoogle Scholar
  17. 17.
    Falany J.L., Falany C.N. 1996. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res. 56, 1551–1555.PubMedGoogle Scholar
  18. 18.
    Falany J.L., Azziz R., Falany C.N. 1998. Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem. Biol. Interact. 109, 329–339.PubMedGoogle Scholar
  19. 19.
    Hume R., Barker E.V., Coughtrie M.W. 1996. Differential expression and immunohistochemical localization of the phenol and hydroxysteroid sulphotransferase enzyme families in the developing lung. Histochem. Cell. Biol. 105, 147–152.CrossRefPubMedGoogle Scholar
  20. 20.
    Kester M.H., Kaptein E., Roest T.J., van Dijk C.H., Tibboel D., Meinl W., Glatt H., Coughtrie M.W., Visser T.J. 1999. Characterization of human iodothyronine sulfotransferases. J. Clin. Endocrinol. Metab. 84, 1357–1364.PubMedGoogle Scholar
  21. 21.
    Raftogianis R., Creveling C., Weinshilboum R., Weisz J. 2000. Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr. 113–124.Google Scholar
  22. 22.
    Raftogianis R.B., Wood T.C., Otterness D.M., van Loon J.A., Weinshilboum R.M. 1997. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun. 239, 298–304.CrossRefPubMedGoogle Scholar
  23. 23.
    Raftogianis R.B., Wood T.C., Weinshilboum R.M. 1999. Human phenol sulfotransferases SULT1A2 and SULT1A1: Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem. Pharmacol. 58, 605–616.CrossRefPubMedGoogle Scholar
  24. 24.
    Carlini E.J., Raftogianis R.B., Wood T.C., Jin F., Zheng W., Rebbeck T.R., Weinshilboum R.M. 2001. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese, and African-American subjects. Pharmacogenetics. 11, 57–68.CrossRefPubMedGoogle Scholar
  25. 25.
    Seth P., Lunetta K.L., Bell D.W., Gray H., et al. 2000. Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res. 60, 6859–6863.PubMedGoogle Scholar
  26. 26.
    Langsenlehner U., Krippl P., Renner W., Yazdani-Biuki B., Eder T., Wolf G., Wascher T.C., Paulweber B., Weitzer W., Samonigg H. 2004. Genetic variants of the sulfotransferase 1A1 and breast cancer risk. Breast Cancer Res. Treat. 87, 19–22.CrossRefPubMedGoogle Scholar
  27. 27.
    Zheng W., Xie D., Cerhan J.R., Sellers T.A., Wen W., Folsom A.R. 2001. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 10, 89–94.PubMedGoogle Scholar
  28. 28.
    Tang D., Rundle A., Mooney L., Cho S., Schnabel F., Estabrook A., Kelly A., Levine R., Hibshoosh H., Perera F. 2003. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res. Treat. 78, 217–222.CrossRefPubMedGoogle Scholar
  29. 29.
    Sillanpaa P., Kataja V., Eskelinen M., Kosma V.M., Uusitupa M., Vainio H., Mitrunen K., Hirvonen A. 2005. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenet. Genomics. 15, 749–752.PubMedGoogle Scholar
  30. 30.
    Shatalova E.G., Walther S.E., Favorova O.O., Rebbeck T.R., Blanchard R.L. 2005. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: A case-series study. Breast Cancer Res. 7, R909–R921.CrossRefPubMedGoogle Scholar
  31. 31.
    Cheng T.C., Chen S.T., Huang C.S., Fu Y.P., Yu J.C., Cheng C.W., Wu P.E., Shen C.Y. 2005. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility. Int. J. Cancer. 113, 345–353.CrossRefPubMedGoogle Scholar
  32. 32.
    Gulyaeva L.F., Zakharova L.Yu., Mikhailova O.N., Prudnikov A.V., Barkov E.S., Gerasimov A.V., Tarkhov A.V., Krasil’nikov S.E. 2004. Molecular biological methods in the diagnosis and treatment of oncological diseases. Meditsina v Kuzbasse. 11, 15–22.Google Scholar
  33. 33.
    Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., Owens I.S. 1992. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 267, 3257–3261.PubMedGoogle Scholar
  34. 34.
    Guillemette C., Millikan R.C., Newman B., Housman D.E. 2000. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 60, 950–956.PubMedGoogle Scholar
  35. 35.
    Ebner T., Remmel R.P., Burchell B. 1993. Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol. Pharmacol. 43, 649–654.PubMedGoogle Scholar
  36. 36.
    Iyer L., King C.D., Whitington P.F., Green M.D., Roy S.K., Tephly T.R., Coffman B.L., Ratain M.J. 1998. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J. Clin. Invest. 101, 847–854.PubMedGoogle Scholar
  37. 37.
    Guillemette C. 2003. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenom. J. 3, 136–158.Google Scholar
  38. 38.
    Ghosh S.S., Sappal B.S., Kalpana G.V., Lee S.W., Chowdhury J.R., Chowdhury N.R. 2001. Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. J. Biol. Chem. 276, 42108–42115.PubMedGoogle Scholar
  39. 39.
    UGP Glucuronosyltransferase Homepage (http://som.flinders.edu.au/FUSA/ClinPharm/UGT/1A1alleles.html).
  40. 40.
    Bosma P.J., Chowdhury J.R., Bakker C., et al. 1995. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N. Engl. J. Med. 333, 1171–1175.CrossRefPubMedGoogle Scholar
  41. 41.
    Mackenzie P.I., Owens I.S., Burchell B., et al. 1997. The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7, 255–269.PubMedGoogle Scholar
  42. 42.
    Beutler E., Gelbart T., Demina A. 1998. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. USA. 95, 8170–8174.PubMedGoogle Scholar
  43. 43.
    Iolascon A., Faienza M.F., Centra M., Storelli S., Zelante L., Savoia A. 1999. (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert’s syndrome. Haematologica. 84, 106–109.PubMedGoogle Scholar
  44. 44.
    Guillemette C., De Vivo I., Hankinson S.E., Haiman C.A., Spiegelman D., Housman D.E., Hunter D.J. 2001. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol. Biomarkers Prev. 10, 711–714.PubMedGoogle Scholar
  45. 45.
    Sparks R., Ulrich C.M., Bigler J., et al. 2004. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res. 6, R488–R498.CrossRefPubMedGoogle Scholar
  46. 46.
    Fisher M.B., Vandenbranden M., Findlay K., Burchell B., Thummel K.E., Hall S.D., Wrighton S.A. 2000. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: Relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics. 10, 727–739.CrossRefPubMedGoogle Scholar
  47. 47.
    Adegoke O.J., Shu X.O., Gao Y.T., Cai Q., Breyer J., Smith J., Zheng W. 2004. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res. Treat. 85, 239–245.CrossRefPubMedGoogle Scholar
  48. 48.
    MPRS Mezhdunarodnyi Protivorakovyi Soyuz. TNM Klassifikatsiya zlokachestvennykh opukholei (International Anticancer Union (UICC): TNM Classification of Malignant Tumors). 2003. St. Petersburg: Eskulap, Nauka RAN.Google Scholar
  49. 49.
    Yarbro J.W., Page D.L., Fielding L.P., Partridge E.E., Murphy G.P. 1999. American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer. 86, 2436–2446.CrossRefPubMedGoogle Scholar
  50. 50.
    Saeki M., Saito Y., Jinno H., et al. 2003. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin. Chem. 49, 1182–1185.PubMedGoogle Scholar
  51. 51.
    Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel’ A.E. 2005. Prognostic factors in breast cancer. Sovrem. Onkol. 7, 4–10.Google Scholar

Copyright information

© Pleiades Publishing, Inc. 2006

Authors and Affiliations

  • E. G. Shatalova
    • 1
    • 2
  • V. I. Loginov
    • 3
  • E. A. Braga
    • 3
  • T. P. Kazubskaja
    • 4
  • M. A. Sudomoina
    • 1
  • R. L. Blanchard
    • 2
  • O. O. Favorova
    • 1
  1. 1.Russian State Medical UniversityMinistry of Health of the Russian FederationMoscowRussia
  2. 2.Fox Chase Cancer CenterPhiladelphiaUSA
  3. 3.State Research Center GosNIIgenetikaMoscowRussia
  4. 4.Blokhin Cancer Research CenterRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations